Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients

Figure 2

Effects of paricalcitol on human RAGE, S100A12/ENRAGE, myeloperoxidase, and pentosidine after 12 weeks of treatment and 2 weeks after stopping paricalcitol. Data are expressed as mean and 95% CI.